Fresh analysis reveals that patients who come off blockbuster slimming jabs like Wegovy and Mounjaro may regain reduced body mass far faster than those who stop traditional lifestyle programs.
Published data in a leading medical journal demonstrates that while overweight individuals often shed about a fifth of their body weight while using the jabs, the weight returns at an average rate of nearly a kilo each month after stopping.
"Users purchasing such treatments should be aware of the risk of quick weight regain when the medication ends," cautioned expert Dr. Susan Jebb.
That rate of regain implies a return to original weight within about one and a half years.
Comparing Therapies
The study, which looked at dozens of studies involving thousands of patients, contrasted the results of GLP-1 agonists with conventional dieting.
Researchers point out that people who lose weight through dieting usually have a less rapid weight regain—approximately 0.1 kg a month—post-intervention.
Explaining the Rapid Regain
Experts believe the mechanism of the jabs explains the accelerated rebound.
GLP-1 drugs mimic a body's own chemical called GLP-1, which moderates feelings of fullness.
"Sustained high doses of the hormone levels far above than normal may cause the body to produce less of its endogenous GLP-1, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.
"Stopping of this GLP-1 'fix' leads to appetite is uncontrolled, making binge eating far more likely."
A Chronic Condition?
Medical guidelines recommend the jabs for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.
Many experts argue that, given the significant potential of relapse, the therapy is often ongoing.
This perspective is echoed by pharmaceutical companies, who say that the findings "underscore the persistent nature of obesity," similar to managing diseases like diabetes.
User Accounts
Individuals who have discontinued the jabs report a powerful resurgence of hunger.
"It felt as if a trigger activating and you're instantly extremely hungry," described one woman.
This challenge is compounded if individuals have not established lasting lifestyle or habit changes during treatment.
Widespread Interest
Recent estimates indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.
- Adoption is more common among women compared to men.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion obtain the medications through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while these medications are potent agents for shedding pounds, they are not a standalone cure and lasting health benefits hinges on ongoing lifestyle management.
